This study describes the social and communicative strategies pharmaceutical companies use to influence NSAID prescribing behaviors and elicits physicians' perceptions and counterbalances to these strategies.
Aaron L. Woofter, MD
Advertisement
Articles by Aaron L. Woofter, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the FDA's Peptide Reversal
2
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
3
Student Mental Health, Success Tied to Future Health and Affordability
4
FDA Approves First Orexin Agonist for Narcolepsy Type 1
5